Abstract:Background and PurposeMetformin, a small molecule, antihyperglycaemic agent, is a well-known activator of AMP-activated protein kinase (AMPK) and protects against cardiac fibrosis. However, the underlying mechanisms remain elusive. TGF1 is a key cytokine mediating cardiac fibrosis. Here, we investigated the effects of metformin on TGF1 production induced by angiotensin II (AngII) and the underlying mechanisms. Experimental ApproachWild-type and AMPK2(-/-) C57BL/6 mice were injected s.c. with metformin or saline and infused with AngII (3mgkg(-1)day(-1)) for 7days. Adult mouse cardiac fibroblasts (CFs) were isolated for in vitro experiments. Key ResultsIn CFs, metformin inhibited AngII-induced TGF1 expression via AMPK activation. Analysis using bioinformatics predicted a potential hepatocyte nuclear factor 4 (HNF4)-binding site in the promoter region of the Tgfb1 gene. Overexpressing HNF4 increased TGF1 expression in CFs. HNF4 siRNA attenuated AngII-induced TGF1 production and cardiac fibrosis in vitro and in vivo. Metformin inhibited the AngII-induced increases in HNF4 protein expression and binding to the Tgfb1 promoter in CFs. In vivo, metformin blocked the AngII-induced increase in cardiac HNF4 protein levels in wild-type mice but not in AMPK2(-/-) mice. Consequently, metformin inhibited AngII-induced TGF1 production and cardiac fibrosis in wild-type mice but not in AMPK2(-/-) mice. Conclusions and ImplicationsHNF4 mediates AngII-induced TGF1 transcription and cardiac fibrosis. Metformin inhibits AngII-induced HNF4 expression via AMPK activation, thus decreasing TGF1 transcription and cardiac fibrosis. These findings reveal a novel antifibrotic mechanism of action of metformin and identify HNF4 as a new potential therapeutic target for cardiac fibrosis. Linked ArticlesThis article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc

Metformin attenuates renal fibrosis in both AMPKα2-dependent and independent manners.

Metformin Attenuates Renal Fibrosis in a Mouse Model of Adenine-Induced Renal Injury Through Inhibiting TGF-β1 Signaling Pathways.

Metformin Prevents Renal Fibrosis In Mice With Unilateral Ureteral Obstruction And Inhibits Ang Ii-Induced Ecm Production In Renal Fibroblasts

Metformin Attenuates Folic-Acid Induced Renal Fibrosis In Mice

Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.

Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney

Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts

AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice

Effects of metformin on expression of AMP-activated protein kinase in rat glomerular mesangial cells

Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms

Metformin Attenuates Cardiac Fibrosis by Inhibiting the Tgf Beta(1)-Smad3 Signalling Pathway

Metformin Protects Against Systolic Overload–Induced Heart Failure Independent of AMP-Activated Protein Kinase Α2

Pharmacological targeting of AMPK to restore glucose and fatty acid metabolism homeostasis attenuates transplanted kidney fibrosis

Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy

Metformin inhibits nuclear factor-κB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro.

Metformin Limits Osteoarthritis Development and Progression Through Activation of AMPK Signalling

Ulinastatin attenuates renal fibrosis by regulating AMPK/HIF-1α signaling pathway-mediated glycolysis

Metformin ameliorates the severity of experimental Alport syndrome

Metformin Attenuates Pressure Overload-Induced Cardiac Hypertrophy Via AMPK Activation

Activation of AMP-activated protein kinase inhibits ER stress and renal fibrosis

Metformin modulates immune cell infiltration into the kidney during unilateral ureteral obstruction in mice